New World Medical (India) Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
as on 10-12-2024
- Paid Up Capital ₹ 3.00 Cr
as on 10-12-2024
- Company Age 55 Year, 9 Months
- Last Filing with ROC 31 Mar 2018
- Open Charges ₹ 2.50 M
as on 10-12-2024
- Revenue %
(FY 2017)
- Profit 21.18%
(FY 2017)
- Ebitda 21.18%
(FY 2017)
- Net Worth -0.36%
(FY 2017)
- Total Assets -0.30%
(FY 2017)
About New World Medical (India)
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2018. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 3.00 Cr.
The company currently has active open charges totaling ₹2.50 M.
Anil Mangal, Kuldeep Agrawal, and Chetan Palikar serve as directors at the Company.
- CIN/LLPIN
U33100DL1969PLC005011
- Company No.
005011
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
15 Mar 1969
- Date of AGM
30 Sep 2018
- Date of Balance Sheet
31 Mar 2018
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at New World Medical (India)?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anil Mangal  | Additional Director | 21-Apr-2017 | Current |
| Kuldeep Agrawal | Director | 28-Jun-2011 | Current |
| Chetan Palikar | Additional Director | 20-Mar-2020 | Current |
Financial Performance of New World Medical (India).
New World Medical (India) Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 21.18% increase in profit. The company's net worth dipped by a decrease of 0.36%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of New World Medical (India)?
In 2017, New World Medical (India) had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Dopson Pharma (India) LimitedActive 42 years 9 months
Anil Mangal, Kuldeep Agrawal and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 01 Feb 1979 | ₹2.50 M | Open |
How Many Employees Work at New World Medical (India)?
Unlock and access historical data on people associated with New World Medical (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of New World Medical (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped New World Medical (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
